Drew Moghanaki, Co-Chair at U.S. Department of Veterans Affairs, shared on LinkedIn:
“Selective SBRT can help patients with metastatic EGFR+ NSCLC get more MILEAGE out of every one of these drugs. Ask a radiation oncologist to learn more.”
Jim Baranski, Executive Director at Lung Cancer Foundation of America, shared Drew Moghanaki’s post on LinkedIn:
“Heads up NSCLC lung cancer patients… check this out and ask your doctor!”